Medicines

Information letters on the availability of medicines

Safety information

Unauthorised medicinal products

Reporting of the use of an unauthorized medicinal product

Quality defects / counterfeit

Regulation of prices and reimbursements

Biosimilars

Border preparations

Covid-19

Marketing authorisation of medicines

Cannabis

Safety Features